Raising the Bar for Diabetes Clinical Trials
With about 34 million Americans living with diabetes, there’s a high chance you or someone you care about personally understands the challenges it presents. At the AdventHealth Translational Research Institute, our scientists, researchers and clinicians are working to find new ways to prevent, treat and ultimately cure all types of diabetes.
If you or a loved one is diagnosed with diabetes, research institutes like ours offer clinical trials that empower you to improve your well-being and help others, too. Keep reading to learn more and find a study.
You could be the breakthrough. Let us help you find a diabetes research study that’s right for you.
Explore Type 1 Studies
-
NCT06062069
CT-868-004 A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of CT-868 Administered for 16 Weeks to Overweight and Obese Adult Participants with Type 1 Diabetes Mellitus
This study is currently enrolling.Research Area: Translational Research for Metabolism and DiabetesResearch Location: Orlando, FloridaStudy Purpose: To evaluate the safety and tolerability of the study drug, CT-868, and to study the effect that CT-868 has on Type 1 Diabetes and weight.
To be enrolled in this study, you must meet...
-
NCT05901831
FINE-ONE: A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the efficacy and safety of Finerenone versus placebo, in addition to standard of care, in participants with chronic kidney disease and type 1 diabetes
This study is currently enrolling.Research Area: Translational Research for Metabolism and DiabetesResearch Location: Orlando, FloridaStudy Purpose: The aim of the study is to demonstrate efficacy of Finerenone when compared to placebo, in addition to standard of care, in delaying the progression of chronic kidney disease (CKD) in...
More clinical trials loaded
Explore Type 2 Studies
-
NCT03761446
REST: The role of type 2 diabetes on skeletal muscle atrophy and recovery following bed rest in older adults
This study is currently enrolling.Associated Conditions: Diabetes-Drug StudyResearch Area: Translational Research for Metabolism and DiabetesResearch Location: Orlando, FloridaStudy Purpose: To better understand the role of Type 2 Diabetes on skeletal muscle atrophy and recovery following bed rest.
Study Duration: 14 weeks
Study Commitment:
2 Screening Visits
5 Pre... -
NCT06131372
NN9388-7700: Efficacy and safety of co-administered cagrilintide s.c. 2.4 mg in combination with semaglutide s.c. 2.4 mg (cagrisema s.c. 2.4 mg/2.4 mg) once-weekly compared to semaglutide, cagrilinitide and placebo in people with chronic kidney disease and type 2 diabetes.
This study is currently enrolling.Research Area: Translational Research for Metabolism and DiabetesResearch Location: Orlando, FloridaStudy Purpose: The purpose of this study is to see whether CagriSema can lower kidney damage. This will be compared to the effects of semaglutide, cagrilintide and placebo.
Study Duration...
More clinical trials loaded
Explore Diabetes and Chronic Kidney Disease Studies
-
NCT06131372
NN9388-7700: Efficacy and safety of co-administered cagrilintide s.c. 2.4 mg in combination with semaglutide s.c. 2.4 mg (cagrisema s.c. 2.4 mg/2.4 mg) once-weekly compared to semaglutide, cagrilinitide and placebo in people with chronic kidney disease and type 2 diabetes.
This study is currently enrolling.Research Area: Translational Research for Metabolism and DiabetesResearch Location: Orlando, FloridaStudy Purpose: The purpose of this study is to see whether CagriSema can lower kidney damage. This will be compared to the effects of semaglutide, cagrilintide and placebo.
Study Duration...
-
NCT05901831
FINE-ONE: A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the efficacy and safety of Finerenone versus placebo, in addition to standard of care, in participants with chronic kidney disease and type 1 diabetes
This study is currently enrolling.Research Area: Translational Research for Metabolism and DiabetesResearch Location: Orlando, FloridaStudy Purpose: The aim of the study is to demonstrate efficacy of Finerenone when compared to placebo, in addition to standard of care, in delaying the progression of chronic kidney disease (CKD) in...
More clinical trials loaded
What To Know About Diabetes Research
Read our answers to frequently asked questions about diabetes research.
-
Q:Question: What questions about diabetes are researchers hoping to answer?
A:Answer:Through our research and diabetes clinical trials, we’re working to understand:
- What new therapies or treatment strategies could benefit those with diabetes?
- What causes diabetes?
- How do lifestyle changes impact diabetes?
- What demographics are most at risk for diabetes?
-
Q:Question: Is it safe to participate in a research study if I have diabetes?
A:Answer:Our caring physicians screen every new patient accepted into a research study to ensure they meet the criteria to safely participate. Your participation is voluntary, and our research team continues to monitor your health and well-being during the length of the study.
-
Q:Question: What are the potential benefits of participating in a research study?
A:Answer:Your participation contributes to new and valuable scientific discoveries that can significantly impact your community. Some potential benefits for you personally may include:
Continue ReadingCollapse Answer- Access to new and advanced therapies and treatment strategies before they’re available to the public
- Improvements in quality of life
- Monetary incentives
-
Q:Question: Is a diabetes diagnosis required in order to participate in a research study?
A:Answer:Our scientists conduct studies that require participation from those with prediabetes, Type 1 and Type 2 diabetes. We also depend on participation from non-diabetic individuals to act as a control group.
-
Q:Question: How does research seek to improve complications and other conditions impacted by diabetes?
A:Answer:Diabetes can impact other conditions such as high blood pressure, heart disease and cognitive abilities by increasing risk factors, affecting recovery time and worsening long-term prognosis.
Continue ReadingCollapse AnswerOur research investigates ways to lessen or eliminate diabetes’ impact on these conditions so diabetic patients are better able to manage them and live healthier lives.
Find Whole-Person Care at Our Diabetes Institute
We understand the challenges living with diabetes presents. You seek care that nurtures your body, calms your mind and comforts your spirit. At the AdventHealth Diabetes Institute, we empower you to achieve your wellness goals with the tools, support, education and compassionate care you deserve to make living a whole life with diabetes within reach.
Contact Us
You could be the breakthrough. Learn how you can help advance the future of health care. Join us at the AdventHealth Research Institute to help find the next cure.